Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein

Journal of Alzheimer's Disease

Volumn 15, Issue 1, 2008, Pages 139-151

  Leuba, Geneviève ^a   Savioz, Armand ^b   Vernay, André ^a   Carnal, Béatrice ^a   Kraftsik, Rudolf ^c   Tardif, Eric ^c   Riederer, Irène ^a   Riederer, Béat Michel ^a,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Aging; Alzheimer; Frontal cortex; MAP2; Plasticity; PSD 95; Spinophilin; Synapses; Synaptophysin; synuclein

Indexed keywords

ALPHA SYNUCLEIN; MICROTUBULE ASSOCIATED PROTEIN 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95; SPINOPHILIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GROUPS BY AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL PLASTICITY; NERVE DEGENERATION; POSTSYNAPTIC MEMBRANE; PREFRONTAL CORTEX; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 52449129626     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-15112     Document Type: Article

References (52)

1. M. Aarts, Y. Liu, L. Liu, S. Besshoh, M. Arundine, J.W. Gurd, Y.T. Wang, M.W. Salter and M. Tymianski, Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions, Science 298 (2002), 846-850.
2. A. Akram, D. Christoffel, A.B. Rocher, C. Bouras, E. Kovari, D.P. Perl, J.H. Morrison, F.R. Herrmann, V. Haroutunian, P. Giannakopoulos and P.R. Hof, Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: Relationship with the progression of Alzheimer's disease, Neurobiol Aging 29 (2008), 1296-1307.
3. C.G. Almeida, D. Tampellini, R.H. Takahashi, P. Greengard, M.T. Lin, E.M. Snyder and G.K. Gouras, Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses, Neurobiol Dis 20 (2005), 187-198.
4. M.C. Bennett, The role of alpha-synuclein in neurodegenerative diseases, Pharmacol Ther 105 (2005), 311-331.
5. D. Bigot, A. Matus and S.P. Hunt, Reorganization of the cytoskeleton in rat neurons following stimulation with excitatory amino acids in vitro, Eur J Neurosci 3 (1991), 551-558.
6. L.I. Binder, A. Frankfurter and L.I. Rebhun, The distribution of tau in the mammalian central nervous system, J Cell Biol 101 (1985), 1371-1378.
7. P.A. Boyle, P.F. Malloy, S. Salloway, D.A. Cahn-Weiner, R. Cohen and J.L. Cummings, Executive dysfunction and apathy predict functional impairment in Alzheimer disease, Am J Geriatr Psychiatry 11 (2003), 214-221.
8. R.L. Buckner, Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate, Neuron 44 (2004), 195-208.
9. T. Bussiere, P.D. Friend, N. Sadeghi, B. Wicinski, G.I. Lin, C. Bouras, P. Giannakopoulos, N.K. Robakis, J.H. Morrison, D.P. Perl and P.R. Hof, Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease, Neuroscience 112 (2002), 75-91.
10. A. Caceres, L.I. Binder, M.R. Payne, P. Bender, L. Rebhun and O. Steward, Differential subcellular localization of tubulin and the microtubule-associated protein MAP2 in brain tissue as revealed by immunocytochemistry with monoclonal hybridoma antibodies, J Neurosci 4 (1984), 394-410.
11. A. Caceres, M.R. Payne, L.I. Binder and O. Steward, Immunocytochemical localization of actin and microtubule-associated protein MAP2 in dendritic spines, Proc Natl Acad Sci U S A 80 (1983), 1738-1742.
12. M.E. Calhoun, B.R. Fletcher, S. Yi, D.C. Zentko, M. Gallagher and P.R. Rapp, Age-related spatial learning impairment is unrelated to spinophilin immunoreactive spine number and protein levels in rat hippocampus, Neurobiol Aging 29 (2008), 1256-1264.
13. H.H. Cheng, S.H. Liu, H.C. Lee, Y.S. Lin, Z.H. Huang, C.I. Hsu, Y.C. Chen and Y.C. Chang, Heavy chain of cytoplasmic dynein is a major component of the postsynaptic density fraction, J Neurosci Res 84 (2006), 244-254.
14. S.E. Counts, M. Nadeem, S.P. Lad, J. Wuu and E.J. Mufson, Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment, J Neuropathol Exp Neurol 65 (2006), 592-601.
15. P. Davidsson and K. Blennow, Neurochemical dissection of synaptic pathology in Alzheimer's disease, Int Psychogeriatr 10 (1998), 11-23.
16. Z.T. Ding, Y. Wang, Y.P. Jiang, Y. Hashizume, M. Yoshida, M. Mimuro, T. Inagaki and T. Iwase, Characteristics of alpha-synucleinopathy in centenarians, Acta Neuropathol (Berl) 111 (2006), 450-458.
17. S. Dracheva, S.A. Marras, S.L. Elhakem, F.R. Kramer, K.L. Davis and V. Haroutunian, N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia, Am J Psychiatry 158 (2001), 1400-1410.
18. P. Giannakopoulos, F.R. Herrmann, T. Bussiere, C. Bouras, E. Kovari, D.P. Perl, J.H. Morrison, G. Gold and P.R. Hof, Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease, Neurology 60 (2003), 1495-1500.
19. K.H. Gylys, J.A. Fein, F. Yang, D.J. Wiley, C.A. Miller and G.M. Cole, Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence, Am J Pathol 165 (2004), 1809-1817.
20. S. Halpain and P. Greengard, Activation of NMDA receptors induces rapid dephosphorylation of the cytoskeletal protein MAP2, Neuron 5 (1990), 237-246.
21. K. Hatanpaa, K.R. Isaacs, T. Shirao, D.R. Brady and S.I. Rapoport, Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease, J Neuropathol Exp Neurol 58 (1999), 637-643.
22. E. Head, M.M. Corrada, K. Kahle-Wrobleski, R.C. Kim, F. Sarsoza, M. Goodus and C.H. Kawas, Synaptic proteins, neuropathology and cognitive status in the oldest-old, Neurobiol Aging (2008), in press, PMID 18006193.
23. W.G. Honer, Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals, Neurobiol Aging 24 (2003), 1047-1062.
24. E.A. Irving, J. McCulloch and D. Dewar, Intracortical perfusion of glutamate in vivo induces alterations of tau and microtubule-associated protein 2 immunoreactivity in the rat, Acta Neuropathol 92 (1996), 186-196.
25. S.B. Jones, G.W. Lanford, Y.H. Chen, M. Morabito, K. Kim and Q. Lu, Glutamate-induced delta-catenin redistribution and dissociation from postsynaptic receptor complexes, Neuroscience 115 (2002), 1009-1021.
26. S. Keck, R. Nitsch, T. Grune and O. Ullrich, Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease, J Neurochem 85 (2003), 115-122.
27. E. Kim and M. Sheng, PDZ domain proteins of synapses, Nat Rev Neurosci 5 (2004), 771-781.
28. L.V. Kristiansen, M. Beneyto, V. Haroutunian and J.H. Meador-Woodruff, Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia, Mol Psychiatry 11 (2006), 737-47, 705.
29. T. Kuriu, A. Inoue, H. Bito, K. Sobue and S. Okabe, Differential control of postsynaptic density scaffolds via actin-dependent and -independent mechanisms, J Neurosci 26 (2006), 7693-7706.
30. T. Lashley, J.L. Holton, E. Gray, K. Kirkham, S.S. O'Sullivan, A. Hilbig, N.W. Wood, A.J. Lees and T. Revesz, Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients, Acta Neuropathol 115 (2008), 417-425.
31. H. Lassmann, R.Weiler, P. Fischer, C. Bancher, K. Jellinger, E. Floor, W. Danielczyk, F. Seitelberger and H. Winkler, Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles, Neuroscience 46 (1992), 1-8.
32. G. Leuba, A. Vernay, D. Vu, C.Walzer, B. Belloir, R. Kraftsik, C. Bouras and A. Savioz, Differential expression of LMO4 protein in Alzheimer's disease, Neuropathol Appl Neurobiol 30 (2004), 57-69.
33. G. Leuba, C. Walzer, A. Vernay, B. Carnal, R. Kraftsik, F. Piotton, F. Marin, C. Bouras. and A. Savioz, Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction, Neurobiol Dis 30 (2008), 408-419.
34. G. Leuba, G. Wernli, A. Vernay, R. Kraftsik, M.H. Mohajeri and K.D. Saini, Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease, Dement Geriatr Cogn Disord 19 (2005), 171-183.
35. S. Love, L.K. Siew, D. Dawbarn, G.K. Wilcock, Y. Ben-Shlomo and S.J. Allen, Premorbid effects of APOE on synaptic proteins in human temporal neocortex, Neurobiol Aging 27 (2006), 797-803.
36. E.B. Mukaetova-Ladinska, F. Garcia-Siera, J. Hurt, H.J. Gertz, J.H. Xuereb, R. Hills, C. Brayne, F.A. Huppert, E.S. Paykel, M. McGee, R. Jakes, W.G. Honer, C.R. Harrington and C.M. Wischik, Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease, Am J Pathol 157 (2000), 623-636.
37. O. Pletnikova, N.West, M.K. Lee, G.L. Rudow, R.L. Skolasky, T.M. Dawson, L. Marsh and J.C. Troncoso, Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases, Neurobiol Aging 26 (2005), 1183-1192.
38. E.M. Quinlan and S. Halpain, Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors, Neuron 16 (1996), 357-368.
39. P.H. Reddy, G. Mani, B.S. Park, J. Jacques, G. Murdoch, W. Whetsell, Jr., J. Kaye and M. Manczak, Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction, J Alzheimers Dis 7 (2005), 103-117.
40. B. Riederer and A. Matus, Differential expression of distinct microtubule-associated proteins during brain development, Proc Natl Acad Sci U S A 82 (1985), 6006-6009.
41. B.M. Riederer, E. Draberova, V. Viklicky and P. Draber, Changes of MAP2 phosphorylation during brain development, J Histochem Cytochem 43 (1995), 1269-1284.
42. B.M. Riederer, A. Guadano-Ferraz and G.M. Innocenti, Difference in distribution of microtubule-associated proteins 5a and 5b during the development of cerebral cortex and corpus callosum in cats: dependence on phosphorylation, Brain Res Dev Brain Res 56 (1990), 235-243.
43. B.M. Riederer, R. Porchet and R.A. Marugg, Differential expression and modification of neurofilament triplet proteins during cat cerebellar development, J Comp Neurol 364 (1996), 704-717.
44. K.P. Riley, D.A. Snowdon, M.F. Desrosiers and W.R. Markesbery, Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study, Neurobiol Aging 26 (2005), 341-347.
45. F. Roselli, M. Tirard, J. Lu, P. Hutzler, P. Lamberti, P. Livrea, M. Morabito and O.F. Almeida, Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses, J Neurosci 25 (2005), 11061-11070.
46. SAS Institute Inc., SAS/STAT User's Guide, vol 1 SAS, Cary, NC, USA, 1989, 1-943 pp.
47. A. Savioz, B.M. Riederer, P. Heutink, P. Rizzu, M. Tolnay, E. Kovari, A. Probst, I.M. Riederer, C. Bouras and G. Leuba, Tau and neurofilaments in a family with frontotemporal dementia unlinked to chromosome 17q21-22, Neurobiol Dis 12 (2003), 46-55.
48. A. Schrattenholz and V. Soskic, NMDA receptors are not alone: dynamic regulation of NMDA receptor structure and function by neuregulins and transient cholesterol-rich membrane domains leads to disease-specific nuances of glutamate-signalling, Curr Top Med Chem 6 (2006), 663-686.
49. D.A. Snowdon, Aging and Alzheimer's disease: lessons from the nun study, Gerontologist 37 (1997), 150-156.
50. D.S. Wang, D.A. Bennett, E. Mufson, E. Cochran and D.W. Dickson, Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly, Neurosci Lett 359 (2004), 104-108.
51. W. Wen, W. Wang and M. Zhang, Targeting PDZ domain proteins for treating NMDA receptor-mediated excitotoxicity, Curr Top Med Chem 6 (2006), 711-721.
52. J. Zaccai, C. Brayne, I. McKeith, F. Matthews and P.G. Ince, Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort, Neurology 70 (2008), 1042-1048.